Journal
FUTURE MICROBIOLOGY
Volume 6, Issue 3, Pages 265-277Publisher
FUTURE MEDICINE LTD
DOI: 10.2217/FMB.11.11
Keywords
Aedes aegypti; alphaviruses; arbovirus; argonaute; dicer; Drosophila melanogaster; flaviviruses; innate immunity; RNAi
Categories
Funding
- NIH/NIAID [AI034014]
Ask authors/readers for more resources
Mosquito-borne arboviruses cause serious diseases in humans that are increasingly becoming public health problems, yet arbovirus infections cause minimal pathology in the mosquito vector, allowing persistent infections and lifelong virus transmission. The principal mosquito innate immune response to virus infections, RNAi, differs substantially from the human immune response and this difference could be the basis for the disparate outcomes of infection in the two hosts. Understanding the mosquito antiviral immune response could lead to strategies for interruption of arbovirus transmission and greatly reduce disease. Research focused on RNAi as the primary mosquito antiviral response has the greatest potential for developing a full understanding of mosquito innate immunity. This article reviews our current knowledge of mosquito antiviral RNAi and charts some of the future directions needed to fill knowledge gaps.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available